In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
The Securities and Exchange Commission has been accused of "over-regulation" in recent years as it has proposed and finalized dozens of rules in a relatively short ...
It's the Summer Solstice, and that means that for most of us the sun is shining, temperatures are heating up, and longer days allow for pursuits ...
When former BlackRock executive Salim Ramji takes the helm next month at Vanguard, the asset management behemoth's board of directors also will install its first-ever independent ...
Former BNY Mellon executive Joseph Keenan spent time during the pandemic learning "all things blockchain," knowledge that has come in handy since he was tapped in ...